RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Free cash flow

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Jun 30, 20251,662+27.65%
Jun 30, 20241,302+126.94%
Jun 30, 2023574+165.19%
Jun 30, 2022216-65.88%
Jun 30, 2021634-10.31%
Jun 30, 2020707+81.10%
Jun 30, 2019390-11.78%
Jun 30, 2018442+25.75%
Jun 30, 2017352-28.11%
Jun 30, 2016489+52.61%
Jun 30, 2015321+0.67%
Jun 30, 2014319-6.10%
Jun 30, 2013339+0.96%
Jun 30, 2012336+55.15%
Jun 30, 2011217

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)